Classification and pathogenesis of vulvovaginal candidiasis

Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):935-9. doi: 10.1016/s0002-9378(85)80004-1.

Abstract

Although candidiasis of the female genital tract is one of the most common of the vaginitides, it is a poorly understood disease entity. Vulvovaginal candidiasis is a monoetiologic disease, but the pathways by which pathogenic expression is attained are sufficiently divergent to constitute a classification schema that influences therapy. For selection of appropriate therapy, the following three broad categories are proposed: (1) primary candidiasis, (2) antibiotic-induced candidiasis, and (3) systemically induced candidiasis.

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Candidiasis, Vulvovaginal / classification*
  • Candidiasis, Vulvovaginal / drug therapy
  • Candidiasis, Vulvovaginal / etiology
  • Clotrimazole / therapeutic use
  • Female
  • Humans
  • Ketoconazole / therapeutic use
  • Risk
  • Vagina / microbiology

Substances

  • Anti-Bacterial Agents
  • Clotrimazole
  • Ketoconazole